Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors

(2009) M. E. Burlone et al.   JOURNAL OF GENERAL VIROLOGY

Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-α

(2009) S. Toma et al.   JOURNAL OF VIRAL HEPATITIS

Antiviral resistance and specifically targeted therapy for HCV (STAT-C)

(2009) A. J. V. Thompson et al.   JOURNAL OF VIRAL HEPATITIS

The autophagy machinery is required to initiate hepatitis C virus replication

(2009) M. Dreux et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level

(2008) Konrad Stadler et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV

(2008) Hussein Hassan Aly et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin

(2008) Jean–François Rossignol et al.   GASTROENTEROLOGY

Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin

(2008) Yaakov Nahmias et al.   HEPATOLOGY

Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure−Property−Activity Relation Model

(2007) Johannes Kornhuber et al.   JOURNAL OF MEDICINAL CHEMISTRY